Skip to main content

Monitoring Allogeneic CAR-T Cells Using Flow Cytometry

  • Protocol
  • First Online:
Cell Reprogramming for Immunotherapy

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2097))

Abstract

Chimeric antigen receptor T cell (CAR-T) therapies have now entered mainstream clinical practice with two approved autologous CAR-T products targeting CD19 and numerous other products in early and late phase clinical trials. This has led to a demand for highly sensitive, specific, and easily reproducible methods to monitor CAR-T cells in patients. Here we describe a flow cytometry based protocol for detection of allogeneic CAR-T cells and for monitoring their phenotype and numbers in blood and bone marrow of patients following CAR-T treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Porter D, Hwang W, Frey N, Lacey S, Shaw P, Loren A, Bagg A, Marcucci K, Shen A, Gonzalez V, Ambrose D, Grupp S, Chew A, Zheng Z, Milone M, Levine B, Melenhorst J, June C (2015) Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci Transl Med 7:303–139

    Article  Google Scholar 

  2. Giavridis T, van der Stegen SJC, Eyquem J, Hamieh M, Piersigilli A (2018) Sadelain CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade. Nat Med 24(6):731–738

    Article  CAS  Google Scholar 

  3. Graham C, Jozwik A, Pepper A, Benjamin R (2018) Allogeneic CAR-T cells: more than ease of access? Cells 7(10). https://doi.org/10.3390/cells7100155

    Article  CAS  Google Scholar 

  4. Torikai H, Reik A, Liu PQ, Zhou Y, Zhang L, Maiti S, Huls H, Miller JC, Kebriaei P, Rabinovich B, Lee DA, Champlin RE, Bonini C, Naldini L, Rebar EJ, Gregory PD, Holmes MC, Cooper LJ (2012) A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. Blood 119(24):5697–5705

    Article  CAS  Google Scholar 

  5. Ren J, Liu X, Fang C, Jiang S, June CH, Zhao Y (2017) Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition. Clin Cancer Res 23(9):2255–2266

    Article  CAS  Google Scholar 

  6. Philip B, Kokalaki E, Mekkaoui L, Thomas S, Straathof K, Flutter B, Marin V, Marafioti T, Chakraverty R, Linch D, Quezada SA, Peggs KS, Pule M (2014) A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy. Blood 124(8):1277–1287

    Article  CAS  Google Scholar 

  7. Poirot L, Philip B, Schiffer-Mannioui C, Le Clerre D, Chion-Sotinel I, Derniame S, Potrel P, Bas C, Lemaire L, Galetto R, Lebuhotel C, Eyquem J, Cheung GW, Duclert A, Gouble A, Arnould S, Peggs K, Pule M, Scharenberg AM, Smith J (2015) Multiplex genome-edited T-cell manufacturing platform for “off-the-shelf” adoptive T-cell immunotherapies. Cancer Res 75(18):3853–3864

    Article  CAS  Google Scholar 

  8. Wang H, Du X, Chen WH, Lou J, Xiao HL, Pan YM, Chen H, An N, Zhang QX (2018) Establishment of a quantitative polymerase chain reaction assay for monitoring chimeric antigen receptor T cells in peripheral blood. Transplant Proc 50(1):104–109

    Article  CAS  Google Scholar 

  9. Kalina T, JG Marvelde TE, van der Velden VHJ, Flores-Montero J, Thűrner D, Böttcher S, Cullen M, Lhermitte L, Sedek L, Mendonça A, Hrusak O, van Dongen JJM, Orfao A (2012) EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Section 3. Design and evaluation of EuroFlow standard operating procedure for establishing optimal compensation settings. Leukemia 26:1986–2010

    Article  CAS  Google Scholar 

  10. Stewart CC, Stewart SJ (1997) Titrating antibodies. In: Robinson JP et al (eds) Current protocols in cytometry. J. Wiley & Sons, New York, pp 4.1–4.4

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reuben Benjamin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Jozwik, A., Dunlop, A., Sanchez, K., Benjamin, R. (2020). Monitoring Allogeneic CAR-T Cells Using Flow Cytometry. In: Katz, S., Rabinovich, P. (eds) Cell Reprogramming for Immunotherapy. Methods in Molecular Biology, vol 2097. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0203-4_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-0203-4_19

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-0202-7

  • Online ISBN: 978-1-0716-0203-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics